Sisomicinネブライザー療法の臨床的検討
書誌事項
- タイトル別名
-
- Treatment of sinusitis and laryngitis by aerosolized Sisomicin.
この論文をさがす
抄録
A study was made of the efficacy and safety of Sisomicin (Extramycin: Bayer) nebulizer in 31 patients with sinusitis treated with 25mg twice a week for 4 weeks or longer and 16 patients with laryngitis were treated with the same dose twice a week for 2 weeks or longer.<br>1. The Sisomicin concentration in the blood was 0.08μg/ml or less in all cases after the nebulizer treatment.<br>Accumulation of Sisomicin in the blood was not observed.<br>2. Subjective symptoms were relieved in 74.2% of the patients with sinusitis, objective signs were relieved in 67.7%, bacteria were eradicated in 52%, and the rate of usefulness was 74.2%.<br>3. Subjective symptoms and objective signs were relieved in 100% of the patients with laryngitis, bacteria were eradicated in 77.8%, and the rate of usefulness was 100%.<br>4. No side effects were observed in any of the patients in these experiments.
収録刊行物
-
- 耳鼻咽喉科臨床
-
耳鼻咽喉科臨床 78 (5), 749-762, 1985
耳鼻咽喉科臨床学会
- Tweet
キーワード
詳細情報 詳細情報について
-
- CRID
- 1390001204263997696
-
- NII論文ID
- 130001808820
-
- ISSN
- 18844545
- 00326313
-
- 本文言語コード
- ja
-
- データソース種別
-
- JaLC
- Crossref
- CiNii Articles
-
- 抄録ライセンスフラグ
- 使用不可